Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Reed John C. Insider active across 2 companies, notably Johnson & Johnson. Aggregated, 8 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €2.7m. History available since 1 May 2024. The latest transaction was filed on 15 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
REED JOHN C is a declarant linked to Johnson & Johnson, where the listed role is EVP, Innovative Medicine, R&D. The filing history includes 7 filings, and across the sampled recent filings the period runs from 2024-05-03 to 2026-02-18, with EUR 0 of buys and EUR 2694533 of sales, while the most frequent transaction nature is Option exercise.